Nanomix's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nanomix's ROA in the fourth quarter of 2022?
Nanomix Corp recorded a cumulative net loss of $-12 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on assets (ROA) of -1191.35%.

However, within the Healthcare sector 1271 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from 36 to 6458.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Total Assets Change	8.43 %	-66.38 %	-77.38 %	2195.07 %	4451.51 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-12	-11	-10	-11	-9
Return On Assets (TTM)	-1191.35 %	-1129.06 %	-668.52 %	-470.06 %	-454.18 %
NNMX's Total Ranking	# 6458	# 36	# 27	# 60	# 31
Total Assets (TTM) in million	1	1	1	1	1
Seq. Total Assets Change	-3.03 %	2.54 %	-14.72 %	27.87 %	-69.93 %
Seq. Net Income Change	-	-	-	-	-

NNMX's 5 Years Annual ROA >> Back to NNMX Management Effectiveness >> Compare NNMX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 632
Sector	# 1272
Overall	# 6235

Return On Assets Statistics
High	Average	Low
176.97 %	-530.73 %	-7933.06 %
(Jun 30 2022)		(Sep 30 2020)

Financial Statements
Nanomix's Assets	$ 1 million	NNMX's Balance sheet
Nanomix's Income	$ -3 million	Quarterly NNMX's Income Statement
NNMX's Income by Division		See NNMX's Income by Division

Annual Return On Assets	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018
Y / Y Total Assets Change	8.43 %	4451.51 %	-16.32 %	-98.35 %	59.28 %
Total Assets in million	1	1	0	0	1
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-12	-9	-1	-4	-4
Annual Return On Assets	-1255.78 %	-1044.99 %	-4562.23 %	-15533.74 %	-250.21 %

NNMX's 5 Years Annual ROA >> Back to NNMX Management Effectiveness >> Compare NNMX ROA to its Competitors

More Return On Assets Ratios
NNMX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NNMX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NNMX's Competitors
Subscribers only: Roa for Nanomix's Suppliers
Subscribers only: Return On Assets for NNMX's Customers

You may also want to know
NNMX's Roi	NNMX's Inventory Turnover Ratio	NNMX's Growth Rates	NNMX's Dividend Comparisons
	NNMX's Profitability Ratios	NNMX's Asset Turnover Ratio	NNMX's Dividend Growth
NNMX's Roe	NNMX's Valuation Ratios	NNMX's Financial Strength Ratios	NNMX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.